Olsen BC, Opheim R, Kristensen VA, Høivik ML, Lund C, Aabrekk TB, Johansen I, Aass Holten KI, Strande V, Glad IF, Bengtson MB, Ricanek P, Detlie TE, Medhus AW, Boyar R, Torp R, Vatn S, Frigstad SO, Valeur J, Bernklev T, Jelsness-Jørgensen LP, Huppertz-Hauss G (2025)
Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort)
Inflamm Bowel Dis (in press)
DOI 10.1093/ibd/izaf047, PubMed 40063582

Bekkelund M, Juul FE, Sandstad O, Valeur J (2025)
[Not Available]
Tidsskr Nor Laegeforen, 145 (2)
DOI 10.4045/tidsskr.24.0655, PubMed 39932094

Razavi HA, Waked I, Qureshi H, Kondili LA, Duberg AS, Aleman S, Tanaka J, Lazarus JV, Low-Beer D, Abbas Z, Rached AA, Aghemo A, Aho I, Akarca US, Al-Busafi SA, Al-Hamoudi WK, Al-Naamani K, Alaama AS, Aldar MM, Alghamdi M, Gonzalez MA, Alserehi H, Anand AC, Asselah T, Assiri AM et al. (2025)
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
J Hepatol (in press)
DOI 10.1016/j.jhep.2025.01.013, PubMed 39914746